Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Moderna, Inc. MRNA

Healthcare  —  Biotechnology
198.88 4.06 2.08% as of 25 Sep
Market cap
$78.8B
P/E
0.0×
S&P 500 Member
Indexes indicate stock being part of an index
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Moderna, Inc. (MRNA) EV/EBITDA

Moderna, Inc. has no meaningful EV/EBITDA: its trailing twelve-month EBITDA is negative. Over the past ten years it has ranged from 0.0× (September 2026) to 125× (June 2021) — the current reading is the lowest in ten years.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 6.3× (7.52%)
FY2021 6.8× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.7× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly

Period EV/EBITDA Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 0.0× —
30 more quarters

Against its own ten years

Low 0.0× High 125×
Ten-year median 0.0×
Current reading's percentile 66

EV/EBITDA against peers

Company EV/EBITDA
INSM Insmed, Inc. compare n/m
RVMD Revolution Medicines, Inc. compare n/m
MRNA Moderna, Inc. n/m
REGN Regeneron Pharmaceuticals, Inc. compare 17.3×
RPRX Royalty Pharma PLC compare 22.0×
VRTX Vertex Pharmaceuticals Incorporated compare 25.2×
ALNY Alnylam Pharmaceuticals, Inc. compare 30.3×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 34.1×
ARGX argenex SE compare 35.1×
Biotechnology industry median 0.7×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on MRNA